Abstract
PREVIOUS studies1 have provided information about the excretion of radioactive metabolites of orally administered 19-norsteroids in the bile, urine and faeces of human subjects. The experiments described in this report were designed to estimate the amount of a radioactive dose of norethynodrel (17α-ethynyl-17β-hydroxy-Δ5(10)-oestren-3-one) or of ethynodiol diacetate (3β,17β-diacetoxy-17α-ethynyl-Δ4-oestrene) which was excreted in the milk of rabbits and of humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Layne, D. S., Golab, T., Arai, K., and Pincus, G., Biochem. Pharmacol., 12, 905 (1963).
Flood, C., Layne, D. S., Ramcharan, S., Rossipal, E., Tait, J. F., and Tait, S. A. S., Acta Endocrinol., 36, 237 (1961).
Lunaas, T., Nature, 198, 288 (1963).
Williams, W. F., J. Dairy Science, 45, 1541 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
PINCUS, G., BIALY, G., LAYNE, D. et al. Radioactivity in the Milk of Subjects receiving Radioactive 19-Norsteroids. Nature 212, 924–925 (1966). https://doi.org/10.1038/212924a0
Issue Date:
DOI: https://doi.org/10.1038/212924a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
